Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1127680 | 0.86 | — | — | |
| SCHEMBL29286895 | 0.81 | TDP1 (0.33) | TDP1KDM4E | |
| SCHEMBL4861560 | 0.81 | TDP1 (0.33) | TDP1KDM4E | |
| SCHEMBL6364868 | 0.80 | TGFBR1 (0.31) | — | |
| SCHEMBL11670289 | 0.79 | TDP1 (0.32) | TDP1KDM4E | |
| SCHEMBL7132286 | 0.78 | TDP1 (0.31) | TDP1KDM4E | |
| SCHEMBL4774722 | 0.77 | — | — | |
| SCHEMBL12836545 | 0.77 | — | — | |
| SCHEMBL20932853 | 0.77 | — | — | |
| SCHEMBL16782434 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | claimed |
| EP-4419062-A1 | COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL | Solventum Intellectual Properties Company (US) | 2024-08-28 | — | — | EP | claimed |
| US-11766386-B2 | Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-09-26 | — | — | US | claimed |
| WO-2023067453-A1 | COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-04-27 | — | — | WO | claimed |
| EP-0118327-B1 | CATIONIC LATICES FROM CONJUGATED DIENES | RHONE-POULENC CHIMIE (FR) | 1987-04-22 | — | — | EP | claimed |
| US-12630582-B2 | Method for biomaterial purification and kits thereof | Life Technologies Corporation (US) | 2026-05-19 | — | — | US | disclosed |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-07-24 | — | — | US | disclosed |
| EP-3534867-B1 | MEDICAL COMPOSITION CONTAINING GUANIDINYL-CONTAINING POLYMER(S) AND CARRAGEENANE(S) | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-06-04 | — | — | EP | disclosed |
| EP-3534866-B1 | METHOD OF DENTAL RETRACTION WITH COMPOSITION WITH GUANIDINYL-CONTAINING POLYMER | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-05-28 | — | — | EP | disclosed |
| US-20250082440-A1 | Composition for Isolating Tissue | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2025-03-13 | — | — | US | disclosed |
| CN-115135307-B | Cell delivery vehicle | 株式会社ITO | 2024-11-22 | — | — | CN | disclosed |
| EP-4419062-A1 | COMPOSITION AND PROCESS FOR TREATING A DISORDER IN THE ORAL CAVITY OF A MAMMAL | Solventum Intellectual Properties Company (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-1616957-A1 | VECTOR | Japan as represented by president of National Cardiovascular Center (JP) | 2006-01-18 | — | — | EP | disclosed |
| US-20050235870-A1 | 2-ethyl-1,3-hexanediol, acetylene glycol surfactant and/or penetrating organic solvent, and humectant; ink jet printing; highly stably ejected and evenly printed on recording media; clogged nozzle problem prevented | SEIKO EPSON CORPORATION | 2005-10-27 | — | — | US | disclosed |
| CN-1642998-A | Basic polymers obtained by hydrogenation | STOCKHAUSEN CHEM FAB GMBH (DE) | 2005-07-20 | — | — | CN | disclosed |
| US-6877851-B2 | Ink set for ink jet recording, ink jet recording process, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2005-04-12 | — | — | US | disclosed |
| US-20040239738-A1 | Ink set for ink jet recording, ink jet recording process, and recorded matter | SEIKO EPSON CORPORATION | 2004-12-02 | — | — | US | disclosed |
| EP-0315718-A2 | Aqueous dispersion of cationic ethylenic copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-05-17 | — | — | EP | disclosed |
| EP-0293087-A1 | Production of electrically conductive ethylene copolymer moldings | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-11-30 | — | — | EP | disclosed |
| EP-0269293-A2 | Composition of a dyeable poly-alpha-olefin and a copolymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1988-06-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630582-B2 | Method for biomaterial purification and kits thereof | CD68, FIBP, BMP2 | TDP1 661/4885KDM4E 3845/4885 |
| US-11766386-B2 | Medical composition containing guanidinyl-containing polymer(s) and carrageenane(s) | GANC, GMPS, MGAM | TDP1 2728/4885KDM4E 588/4885 |
| US-20250235390-A1 | Composition and Process for Treating a Disorder in the Oral Cavity of a Mammal | GSDMD, PIGS, GANC | TDP1 1508/4885KDM4E 3077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.